N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer-Reference-Cited by-同舟云学术

N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer

Published:2023-09-27 Issue: Volume: Page:
ISSN:0340-6717
Container-title:Human Genetics
language:en
Short-container-title:Hum. Genet.

Author:

Liang Yingke,Yin Wenjun,Cai Zhouda,Luo Hongwei,Liu Qinwei,Zhong Chuanfan,Chen Jiahong,Lin Zhuoyuan,Huang Yaqiang,Liang Zhenguo,Deng Junhong,Zhong Weide,Cai Chao,Lu Jianming^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

https://link.springer.com/content/pdf/10.1007/s00439-023-02603-8.pdf

Reference51 articles.

1. Angeles AK, Heckmann D, Flosdorf N et al (2020) The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14–3-3ε-FOXO pathway. Mol Cancer Res 18:1545–1559. https://doi.org/10.1158/1541-7786.Mcr-20-0021

2. Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20:303–322. https://doi.org/10.1038/s41568-020-0253-2

3. Carrillo-Reixach J, Torrens L, Simon-Coma M et al (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73:328–341. https://doi.org/10.1016/j.jhep.2020.03.025

4. Chen M, Wei L, Law CT et al (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67:2254–2270. https://doi.org/10.1002/hep.29683

5. de Winter JC, Gosling SD (2016) Potter J Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: a tutorial using simulations and empirical data. Psychol Methods 21:273–90. https://doi.org/10.1037/met0000079

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNAs: recent insights, remaining challenges, and exciting new directions;Human Genetics;2024-07

2. Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review);Oncology Reports;2024-05-13